Evaluation of Cardiac Chest Pain in Suspected Acute Coronary Syndrome
Patients presenting with suspected acute coronary syndrome require immediate ECG within 10 minutes of presentation, followed by risk stratification using high-sensitivity cardiac troponin measurements and clinical decision pathways to determine disposition and management. 1, 2
Initial Assessment and ECG Interpretation
Immediate Actions
- Obtain a 12-lead ECG within 10 minutes of patient presentation to differentiate between STEMI and non-ST-segment elevation ACS (NSTE-ACS). 3, 4, 1, 2
- Administer aspirin 162-325 mg (chewed, non-enteric coated) immediately unless contraindicated. 5
- Activate emergency medical services (9-1-1) for transport if not already done. 1, 6
ECG Classification
The ECG determines the initial management pathway: 3, 4, 2
STEMI (30% of ACS cases):
- ST-segment elevation ≥1 mm in ≥2 contiguous leads (or ≥2 mm in V2-V3 for men ≥40 years, ≥2.5 mm for men <40 years, ≥1.5 mm for women in V2-V3) 2
- Requires immediate reperfusion with primary PCI within 120 minutes or fibrinolytic therapy if PCI unavailable 2, 7
NSTE-ACS (70% of ACS cases):
- ST-segment depression ≥0.5 mm, T-wave inversion >1 mm, transient ST-elevation, or normal ECG 3, 4, 2
- Proceed to troponin-based risk stratification 3, 4
Critical pitfall: If initial ECG is nondiagnostic but clinical suspicion remains high, obtain supplemental leads V7-V9 to detect posterior MI and perform serial ECGs. 1
Cardiac Biomarker Assessment
High-Sensitivity Troponin Protocols
For patients without ST-elevation, implement one of these validated clinical decision pathways: 1, 8
0-Hour/1-Hour Protocol (ESC 0/1h algorithm):
- Initial hs-cTn at presentation (time 0)
- Repeat at 1 hour
- Rule-out criteria: hs-cTnT <5 ng/L or hs-cTnI below limit of detection at both timepoints (requires symptom onset ≥3 hours prior) 1, 8
- Rule-in criteria: hs-cTn >99th percentile with appropriate rise/fall pattern 3, 4
0-Hour/3-Hour Protocol:
- Initial hs-cTn at presentation
- Repeat at 3 hours
- Recommended time intervals: 1-3 hours for high-sensitivity troponin, 3-6 hours for conventional troponin 1
Troponin Interpretation
Diagnostic criteria for acute MI: 3, 4
- Detection of rise and/or fall of cardiac biomarker (preferably hs-cTn) with at least one value above 99th percentile upper reference limit
- PLUS at least one of: symptoms of ischemia, new ischemic ECG changes, development of pathological Q waves, imaging evidence of new loss of viable myocardium, or intracoronary thrombus
Risk Stratification
High-Risk Features Requiring Immediate Invasive Strategy
Patients with any of the following require coronary angiography within 24 hours (or immediately if very high risk): 9, 4
- Recurrent or ongoing chest pain with dynamic ST-segment changes (particularly ST-depression or transient ST-elevation)
- Elevated troponin levels
- Hemodynamic instability (hypotension, pulmonary edema)
- Major arrhythmias (repetitive ventricular tachycardia, ventricular fibrillation)
- Early post-infarction unstable angina
- Diabetes mellitus
- Marked ST-segment depression on 12-lead ECG
- Heart failure
Low-Risk Identification
Patients with <1% 30-day risk of death or MACE are designated low-risk and may be appropriate for early discharge: 1
HEART Score (0-3 points = low risk): 10
- Likelihood ratio for ruling out ACS: 0.20 (95% CI: 0.13-0.30)
TIMI Score (0-1 points = low risk): 10
- Likelihood ratio for ruling out ACS: 0.31 (95% CI: 0.23-0.43)
Observation Period and Serial Assessment
For patients in the intermediate-risk zone: 9, 8
- 6-12 hour observation period with continuous ECG monitoring
- Obtain second troponin measurement at 6-12 hours if using conventional assays 9
- Record 12-lead ECG with any recurrent chest pain episodes 9
- Consider echocardiography to assess left ventricular function and exclude other causes 9
- Monitor for hemodynamic instability (hypotension, pulmonary rales) 9
Additional Diagnostic Testing
Mandatory Initial Tests
- Chest radiograph to evaluate for alternative cardiac, pulmonary, and thoracic causes 1
- Hemoglobin to detect anemia 9
Physical Examination Red Flags
Look specifically for: 6
- Aortic dissection: Sudden severe chest/back pain with pulse differential between limbs
- Pulmonary embolism: Tachycardia, dyspnea, accentuated P2
- Valvular disease: Characteristic murmurs (aortic stenosis, aortic regurgitation, acute mitral regurgitation)
- Pericarditis: Pain worse supine, friction rub
- Pneumothorax: Unilateral absence of breath sounds
Important caveat: Chest tenderness on palpation or pain varying with breathing/position makes ACS less likely but does not exclude it. 6, 10
Initial Medical Management for NSTE-ACS
Once NSTE-ACS is diagnosed, initiate: 9
- Aspirin 75-150 mg daily (or clopidogrel if aspirin contraindicated)
- Low molecular weight heparin or unfractionated heparin
- Beta-blocker (unless contraindicated; use calcium antagonist as alternative)
- Oral or intravenous nitrates for persistent/recurrent chest pain
- High-intensity statin therapy (preferably with ezetimibe in acute setting) 11, 12
Critical timing note: Omit clopidogrel if patient likely to undergo CABG within 5 days. 9
Common Pitfalls to Avoid
- Do not rely on normal ECG alone to exclude ACS—many NSTE-ACS patients have nonspecific or normal ECGs 3, 4, 2
- Do not use single troponin measurement in isolation; serial measurements are essential unless using validated 0-hour rule-out protocols 1
- Do not discharge patients with ongoing symptoms even if initial troponin is negative—repeat measurement required 9
- Do not assume new LBBB equals STEMI—this occurs infrequently and requires clinical correlation 2
- Between 2-5% of ACS patients are inappropriately discharged from emergency departments, so maintain high clinical suspicion 13